Q32 Bio Inc. Share Price
QTTBQ32 Bio Inc. Stock Performance
Open $3.28 | Prev. Close $3.34 | Circuit Range N/A |
Day Range $3.27 - $3.44 | Year Range $1.34 - $6.31 | Volume 4,127 |
Average Traded $3.33 |
Q32 Bio Inc. Share Price Chart
About Q32 Bio Inc.
Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human antiinterleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition. The company was founded in 2017 and is based in Waltham, Massachusetts.
Q32 Bio Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
02-Jan-26 | $3.28 | $3.43 | +4.57% |
31-Dec-25 | $3.18 | $3.28 | +2.50% |
30-Dec-25 | $3.21 | $3.20 | -0.93% |
29-Dec-25 | $3.25 | $3.23 | +0.31% |
26-Dec-25 | $3.12 | $3.22 | +1.10% |
24-Dec-25 | $3.15 | $3.19 | +2.25% |
23-Dec-25 | $3.03 | $3.12 | +2.64% |